Drug Target Review2025-02-27T09:00:18
Researchers have identified a small gene, SCN10a-short, that could enable gene therapy to treat malignant cardiac arrhythmias. This discovery offers the potential for a one-time treatment, reducing the reliance on lifelong medication and invasive procedures.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-31T06:00:00Z
Contributor Dr Davinder Ramsingh, Drug Target Review
2026-05-12T09:31:00
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2023-07-04T10:05:58
Sponsored by Revvity
2026-05-22T07:38:00
Contributor Dr Helen Bright, Drug Target Review
2023-01-06T16:37:30
Sponsored by Catalent
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud